SCHEMBL6560819

SCHEMBL6560819

ON=C1CCOc2ccc(F)cc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.62
ALDH1A1 P00352 2/20 0.62
L3MBTL1 Q9Y468 2/20 0.62
FABP6 P51161 1/20 0.46
NPSR1 Q6W5P4 3/20 0.42
CTSL P07711 1/20 0.42
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
ALOX12 P18054 1/20 0.39
NFKB1 P19838 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NOTUM Q6P988 1/20 0.37
PIK3CA P42336 3/20 0.36
PIK3CB P42338 3/20 0.36
PIK3CG P48736 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25937556 1.00 KDM4E (0.62) KDM4EALDH1A1L3MBTL1FABP6NPSR1
SCHEMBL6560814 1.00 KDM4E (0.62) KDM4EALDH1A1L3MBTL1FABP6NPSR1
SCHEMBL19913024 0.87 KDM4E (0.48) KDM4EALDH1A1L3MBTL1FABP6
SCHEMBL30411155 0.87 KDM4E (0.48) KDM4EALDH1A1L3MBTL1FABP6
SCHEMBL15716874 0.87 KDM4E (0.48) KDM4EALDH1A1L3MBTL1FABP6
SCHEMBL15716872 0.87 KDM4E (0.48) KDM4EALDH1A1L3MBTL1FABP6
SCHEMBL20205674 0.83 KDM4E (0.62) KDM4EALDH1A1L3MBTL1FABP6NPSR1
SCHEMBL10884161 0.83 KDM4E (0.58) KDM4EALDH1A1L3MBTL1FABP6NPSR1
SCHEMBL10884159 0.83 KDM4E (0.58) KDM4EALDH1A1L3MBTL1FABP6NPSR1
SCHEMBL1982627 0.81 KDM4E (0.56) KDM4EALDH1A1L3MBTL1FABP6NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023144793-A1 POL THETA INHIBITORS RHIZEN PHARMACEUTICALS AG (CH) 2023-08-03 WO disclosed
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
EP-0856514-B1 8-substituted-1,3,8-triazaspiro[4.5]decan-4-on derivatives HOFFMANN LA ROCHE (CH) 2001-06-13 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
US-6071925-A ANTIDEPRESSANTS, ANTICONVULSANTS OR ANTIANXIETY AGENTS, ALSO FOR TREATMENT OF MEMORY LOSS IN ALZHEIMER'S DISEASE HOFFMANN-LA ROCHE INC. (US) 2000-06-06 US disclosed
EP-0856514-A1 8-substituted-1,3,8-triazaspiro[4.5]decan-4-on derivatives F. HOFFMANN-LA ROCHE AG (CH) 1998-08-05 EP disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed